Clinical Context
A typical patient is a 35–60 year-old referred for cytogenetic testing after abnormal findings on prenatal screening, hematologic workup, or tumor analysis. The clinician orders a cytogenetic assay that is not otherwise specified in the CPT code set, such as a novel fluorescence in situ hybridization (FISH) probe panel tailored to a rare chromosomal rearrangement, expanded karyotype with specialized culture conditions, or an uncommon molecular cytogenetic technique developed for research-use validation before commercialization. The workflow begins with specimen collection (peripheral blood, bone marrow, amniotic fluid, chorionic villus sampling, or surgical tumor tissue), proper labeling and transport to a cytogenetics laboratory, accessioning and test selection, specialized specimen processing and cell culture as required, execution of the unique cytogenetic assay, interpretation by a board-certified cytogeneticist or pathologist, and generation of a detailed report for the ordering provider. Billing uses 88299 when no specific CPT code exists for the exact cytogenetic procedure performed. Typical sites of service include hospital outpatient laboratories, independent reference laboratories, academic medical center cytogenetics labs, and specialized molecular diagnostic centers. Common clinical indications include unexplained congenital anomalies, recurrent pregnancy loss, unexplained infertility with suspected chromosomal causes, hematologic malignancies with atypical cytogenetic findings, and tumor profiling when non‑standard cytogenetic tests are required.